Cited Articles for PMCID: 2719009

Year	Number of Results
1986	1
1990	1
1992	1
1994	2
1998	2
1999	3
2000	3
2001	6
2002	3
2003	2
2004	5
2005	7
2006	5
2007	1
2024	0

1

Oncolytic HSV and erlotinib inhibit tumor growth and angiogenesis in a novel malignant peripheral nerve sheath tumor xenograft model.

Mahller YY, Vaikunth SS, Currier MA, Miller SJ, Ripberger MC, Hsu YH, Mehrian-Shai R, Collins MH, Crombleholme TM, Ratner N, Cripe TP. Mahller YY, et al. Mol Ther. 2007 Feb;15(2):279-86. doi: 10.1038/sj.mt.6300038. Mol Ther. 2007. PMID: 17235305 Free article.

2

p16INK4A in oral squamous cell carcinomas--a correlation with biological behaviors: immunohistochemical and FISH analysis.

Suzuki H, Sugimura H, Hashimoto K. Suzuki H, et al. J Oral Maxillofac Surg. 2006 Nov;64(11):1617-23. doi: 10.1016/j.joms.2005.11.097. J Oral Maxillofac Surg. 2006. PMID: 17052587

3

Multiplex ligation-dependent probe amplification: a diagnostic tool for simultaneous identification of different genetic markers in glial tumors.

Jeuken J, Cornelissen S, Boots-Sprenger S, Gijsen S, Wesseling P. Jeuken J, et al. J Mol Diagn. 2006 Sep;8(4):433-43. doi: 10.2353/jmoldx.2006.060012. J Mol Diagn. 2006. PMID: 16931583 Free PMC article.

4

Epigenetic silencing of the PTEN gene in melanoma.

Mirmohammadsadegh A, Marini A, Nambiar S, Hassan M, Tannapfel A, Ruzicka T, Hengge UR. Mirmohammadsadegh A, et al. Cancer Res. 2006 Jul 1;66(13):6546-52. doi: 10.1158/0008-5472.CAN-06-0384. Cancer Res. 2006. PMID: 16818626

5

PTEN activity could be a predictive marker of trastuzumab efficacy in the treatment of ErbB2-overexpressing breast cancer.

Fujita T, Doihara H, Kawasaki K, Takabatake D, Takahashi H, Washio K, Tsukuda K, Ogasawara Y, Shimizu N. Fujita T, et al. Br J Cancer. 2006 Jan 30;94(2):247-52. doi: 10.1038/sj.bjc.6602926. Br J Cancer. 2006. PMID: 16404430 Free PMC article.

6

Mutation and expression of PDGFRA and KIT in malignant peripheral nerve sheath tumors, and its implications for imatinib sensitivity.

Holtkamp N, Okuducu AF, Mucha J, Afanasieva A, Hartmann C, Atallah I, Estevez-Schwarz L, Mawrin C, Friedrich RE, Mautner VF, von Deimling A. Holtkamp N, et al. Carcinogenesis. 2006 Mar;27(3):664-71. doi: 10.1093/carcin/bgi273. Epub 2005 Dec 15. Carcinogenesis. 2006. PMID: 16357008

7

The distinctive nature of HER2-positive breast cancers.

Burstein HJ. Burstein HJ. N Engl J Med. 2005 Oct 20;353(16):1652-4. doi: 10.1056/NEJMp058197. N Engl J Med. 2005. PMID: 16236735 No abstract available.

8

EGFR blockade by cetuximab alone or as combination therapy for growth control of hepatocellular cancer.

Huether A, Höpfner M, Baradari V, Schuppan D, Scherübl H. Huether A, et al. Biochem Pharmacol. 2005 Nov 25;70(11):1568-78. doi: 10.1016/j.bcp.2005.09.007. Epub 2005 Oct 13. Biochem Pharmacol. 2005. PMID: 16226226

9

The NF1 tumor suppressor critically regulates TSC2 and mTOR.

Johannessen CM, Reczek EE, James MF, Brems H, Legius E, Cichowski K. Johannessen CM, et al. Proc Natl Acad Sci U S A. 2005 Jun 14;102(24):8573-8. doi: 10.1073/pnas.0503224102. Epub 2005 Jun 3. Proc Natl Acad Sci U S A. 2005. PMID: 15937108 Free PMC article.

10

Activation of the neuregulin-1/ErbB signaling pathway promotes the proliferation of neoplastic Schwann cells in human malignant peripheral nerve sheath tumors.

Stonecypher MS, Byer SJ, Grizzle WE, Carroll SL. Stonecypher MS, et al. Oncogene. 2005 Aug 25;24(36):5589-605. doi: 10.1038/sj.onc.1208730. Oncogene. 2005. PMID: 15897877

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

38 results

Results by year